Vulvovaginal candidiasis: Symptomatology, risk factors and concomitant anal colonization;Candidíase vulvovaginal: Sintomatologia, fatores de risco e colonização anal concomitante

Revista Brasileira de Ginecologia e Obstetricia

Volumn 29, Issue 1, 2007, Pages 3-9

  De Holanda, Antônio Arildo Reginaldo ^a,c   Fernandes, Ana Cristina Santos ^a   Bezerra, Christiane Medeiros ^a   Ferreira, Maria Ângela Fernandes ^a   De Holanda, Manoel Reginaldo Rocha ^a,b   Holanda, Julita De Campos Pipolo ^a   Milan, Eveline Pipolo ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^b MINISTÉRIO DA SAÚDE   (Brazil)

^c NONE   (Austria)

Author keywords

Anal canal microbiology; Candidiasis, vulvovaginal diagnosis; Risk factors; Vagina microbiology; Vulvovaginitis epidemiology

Indexed keywords

EID: 34247386259     PISSN: 01007203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Fidel PL Jr. Distinct protective host defenses against oral and vaginal candidiasis. Med Mycol. 2002;40(4):359-75.
2. Corrigan EM, Clancy RL, Dunkley ML, Eyers FM, Beagley KW. Cellular immunity in recurrent vulvovaginal candidiasis. Clin Exp Immunol. 1998;111(3):574-8.
3. Dan M, Poch F, Levin D. High rate of vaginal infections caused by non-C. albicans species among asymptomatic women. Med Mycol. 2002;40(4):383-6.
4. Rylander E, Berglund AL, Krassny C, Petrini B. Vulvovaginal candida in a young sexually active population: prevalence and association with oro-genital sex and frequent pain at intercourse. Sex Transm Infect. 2004;80(1):54-7.
5. Dan M, Kaneti N, Levin D, Poch F, Samra Z. Vaginitis in a gynecologic practice in Israel: causes and risk factors. Isr Med Assoc J. 2003;5(9):629-32.
6. Haefner HK. Current evaluation and management of vulvovaginitis. Clin Obstet Gynecol. 1999;42(2):184-95.
7. Mardh PA, Rodrigues AG, Genc M, Novikova N, Martinez-de-Oliveira J, Guaschino S. Facts and myths on recurrent vulvovaginal candidosis-a review on epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy. Int J STD AIDS. 2002;13(8):522-39.
8. Martens MG, Hoffman P, El-Zaatari M. Fungal species changes in the female genital tract. J Low Genit Tract Dis. 2004;8(1):21-4.
9. Nyirjesy P. Chronic vulvovaginal candidiasis. Am Fam Physician. 2001;63(4):697-702.
10. Jackson ST, Mullings AM, Rainford L, Miller A. The epidemiology of mycotic vulvovaginitis and the use of antifungal agents in suspected mycotic vulvovaginitis and its implications for clinical practice. West Indian Med J. 2005;54(3):192-5.
11. Rivero M, Centeno S, Díaz J. Frecuencia de especies de candida aisladas en pacientes embarazadas con vulvovaginitis. Rev Soc Venez Microbiol. 2003;23(2):148-52.
12. Ozcan SK, Budak F, Yucesoy G, Susever S, Willke A. Prevalence, susceptibility profile and proteinase production of yeasts causing vulvovaginitis in Turkish women. APMIS. 2006;114(2):139-45.
13. Ferrazza MHSH, Maluf MLF, Consolaro MEL, Shinobu CS, Svidzinski TIE, Batista MR. Caracterização de leveduras isoladas da vagina e sua associação com candidíase vulvovaginal em duas cidades do sul do Brasil. Rev Bras Ginecol Obstet. 2005;27(2):58-63.
14. Lopes Consolaro ME, Aline Albertoni T, Shizue Yoshida C, Mazucheli J, Peralta RM, Estivalet Svidzinski TI. Correlation of candida species and symptoms among patients with vulvovaginal candidiasis in Maringa, Parana, Brazil. Rev Iberoam Micol. 2004;21(4):202-5.
15. Dennerstein G. Pathogenesis and treatment of genital candidiasis. Aust Fam Psysician. 1998;27(5):363-9.
16. Rosa MI, Rumel D. Fatores associados à candidíase vulvovaginal: estudo exploratório. Rev Bras Ginecol Obstet. 2004;26(1):65-70.
17. de Leon EM, Jacober SJ, Sobel JD, Foxman B. Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect Dis. 2002;2:1.
18. Sobel JD. Vaginal infections in adult women. Med Clin North Am. 1990;74(6):1573-602.
19. Patel DA, Gillespie B, Sobel JD, Leaman D, Nyirjesy P, Weitz MV, et al. Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy: results of a prospective cohort study. Am J Obstet Gynecol. 2005;190(3):644-53.
20. Candido RC, Torqueti Toloi MR, Franceschini SA, Ramos García F, Zaror L. Fosfolipasa, proteinasa y morfotipos de Candida albicans aisladas de vagina y ano. Rev Chil Cienc Méd Biol. 1998;8(1):25-9.
21. Alves SH, Milan EP, de Laet Sant'Ana P, Oliveira LO, Santurio JM, Colombo AL. Hypertonic sabouraud broth as a simple and powerful test for Candida dubliniensis screening. Diagn Microbiol Infect Dis. 2002;43(1):85-6.
22. Tintelnot K, Haase G, Seibold M, Bergmann F, Staemmler M, Franz T, et al. Evaluation of phenotypic markers for selection and identification of Candida dublinienses. J Clin Microbiol. 2000;38(4):1599-608.
23. Kurtzman CP, Fell JW. The yeasts, a taxonomic study. Amsterdam: Elsevier Science; 1998.
24. Soll DR, Galask R, Schmid J, Hanna C, Mac K, Morrow B. Genetic dissimilarity of commensal strains of Candida spp. carried in different anatomical locations of the same healthy women. J Clin Microbiol. 1991;29(8):1702-10.